General Information of Drug Transporter (DT)
DT ID DTD0491 Transporter Info
Gene Name SLC9A7
Transporter Name Sodium/hydrogen exchanger 7
Gene ID
84679
UniProt ID
Q96T83
Post-Translational Modification of This DT
Overview of SLC9A7 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A7 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

145

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC9A7 Asparagine 145 has the potential to affect its expression or activity.

  Leucine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Unaffected Membrane trafficking [3]

Role of PTM

No Significant Effect

Modified Residue

Leucine

Modified Location

515

Modified State

Leucine to Phenylalanine mutation

Experimental Material(s)

Chinese hamster ovary (AP-1) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Removal of the N-glycosylation at SLC9A7 Leucine 515 (i.e. Leucine to Phenylalanine mutation) have been reported to have no significant alteration in its membrane trafficking.

Phosphorylation

  Serine

          9 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A7 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

11

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Serine 11 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9A7 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

160

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Serine 160 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC9A7 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

198

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Serine 198 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC9A7 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

244

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Serine 244 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC9A7 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

545

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Serine 545 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC9A7 [7] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

573

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Serine 573 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC9A7 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

693

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Serine 693 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC9A7 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

694

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Serine 694 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC9A7 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

695

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Serine 695 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A7 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

691

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Threonine 691 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A7 [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

556

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A7 Tyrosine 556 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A7 [15]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

709

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC9A7 Lysine 709 has the potential to affect its expression or activity.
References
1 Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol. 2009 Apr;27(4):378-86.
2 Molecular cloning and characterization of a novel (Na+,K+)/H+ exchanger localized to the trans-Golgi network. J Biol Chem. 2001 May 18;276(20):17387-94.
3 A recurrent missense variant in SLC9A7 causes nonsyndromic X-linked intellectual disability with alteration of Golgi acidification and aberrant glycosylation. Hum Mol Genet. 2019 Feb 15;28(4):598-614.
4 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
5 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
6 Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator. Proteomics. 2017 Nov;17(22):10.1002/pmic.201700214.
7 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
8 Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
9 Improved Method for Determining Absolute Phosphorylation Stoichiometry Using Bayesian Statistics and Isobaric Labeling. J Proteome Res. 2017 Nov 3;16(11):4217-4226.
10 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
11 Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
12 Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood Adv. 2018 Oct 9;2(19):2554-2567.
13 Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
14 Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis. Anal Chem. 2017 Sep 5;89(17):9307-9314.
15 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.